Long-term safety and tolerability of tozorakimab in patients with COPD and history of exacerbations

Trial Identifier: D9180C00015
Sponsor: AstraZeneca
Collaborator:
Clinact, Multihealth Group
Contract Research Organization
Start Date: May 2026
Primary Completion Date: December 2028
Study Completion Date: December 2028
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
FR Aix en Provence, FR, 13616
FR Brest Cedex, FR, 29609
FR GLEIZE, FR, 69400
FR GRENOBLE Cedex 9, FR, 38043
FR LYON CEDEX, FR, 69317
FR Marseille, FR, 13015
FR Montpellier Cedex 5, FR, 34295
FR PESSAC, FR, 33600
FR Pringy Cedex, FR, 74374
FR Quimper, FR, 29000
FR Saint-Herblain, FR, 44800
FR Toulouse, FR, 31000